Natera (NTRA) is a $1.25B provider of genetic testing services trading 4.4X EV/Sales and grew revenues 22.9% in 2018 with an outlook for 11% growth in 2019 before accelerating back to 18-20% growth in 2020/2021. NTRA remains far from profitability w...